205 related articles for article (PubMed ID: 37822394)
21. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
[TBL] [Abstract][Full Text] [Related]
22. A Study on the Association of Psoriasis with Metabolic Disorders.
Jadhav N; Nadkarni N; Patil S
J Assoc Physicians India; 2019 Apr; 67(4):52-54. PubMed ID: 31309797
[TBL] [Abstract][Full Text] [Related]
23. The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).
Hu Y; Chen J; Yang L; Chen P; Li J; Chen L; Chen J; Huang X; Zhang Y; Bu S; Huang Q
J Clin Transl Endocrinol; 2014 Dec; 1(4):133-139. PubMed ID: 29159094
[TBL] [Abstract][Full Text] [Related]
24. A Hospital Based Observational Study to Detect Non-Alcoholic Steatohepatitis by Acoustic Radiation Force Impulse in Individuals with Diabetes Mellitus and Metabolic Syndrome.
Singhai A; Shaji N
Mymensingh Med J; 2023 Jul; 32(3):847-854. PubMed ID: 37391984
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
Shipovskaya AA; Dudanova OP; Kurbatova IV
Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940
[TBL] [Abstract][Full Text] [Related]
27. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
Chen Y; Wang XJ; Jin HL; Jin L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
[TBL] [Abstract][Full Text] [Related]
28. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
[TBL] [Abstract][Full Text] [Related]
29. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.
Tutunchi H; Naeini F; Ebrahimi-Mameghani M; Mobasseri M; Naghshi S; Ostadrahimi A
Int J Clin Pract; 2021 Jun; 75(6):e14131. PubMed ID: 33683797
[TBL] [Abstract][Full Text] [Related]
30. Lipid Accumulation Product Index as Visceral Obesity Indicator in Psoriasis: A Case-control Study.
Ganguly S; Ray L; Kuruvila S; Nanda SK; Ravichandran K
Indian J Dermatol; 2018; 63(2):136-140. PubMed ID: 29692455
[TBL] [Abstract][Full Text] [Related]
31. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
33. Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter.
Gandha N; Wibawa LP; Jacoeb TNA; Sulaiman AS
Psoriasis (Auckl); 2020; 10():39-44. PubMed ID: 33117662
[TBL] [Abstract][Full Text] [Related]
34. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
Bellinato F; Gisondi P; Mantovani A; Girolomoni G; Targher G
J Endocrinol Invest; 2022 Jul; 45(7):1277-1288. PubMed ID: 35147926
[TBL] [Abstract][Full Text] [Related]
35. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the chosen parameters of metabolic status in patients with psoriasis].
Kacalak-Rzepka A; Kiedrowicz M; Maleszka R
Ann Acad Med Stetin; 2013; 59(2):12-7. PubMed ID: 25026745
[TBL] [Abstract][Full Text] [Related]
37. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
Madanagobalane S; Anandan S
Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
[TBL] [Abstract][Full Text] [Related]
38. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
39. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
40. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
